Disc Medicine, Inc.·4

Mar 4, 4:55 PM ET

Savage William Jacob 4

4 · Disc Medicine, Inc. · Filed Mar 4, 2026

Insider Transaction Report

Form 4
Period: 2026-03-02
Savage William Jacob
Chief Medical Officer
Transactions
  • Sale

    Common Stock

    [F1][F2]
    2026-03-02$65.52/sh4,392$287,77288,197 total
  • Sale

    Common Stock

    [F1][F3]
    2026-03-02$66.41/sh2,986$198,29785,211 total
Footnotes (3)
  • [F1]These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 2, 2025.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.00 to $65.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.03 to $66.88, inclusive.
Signature
By: /s/ Rahul Khara, as Attorney-in-Fact|2026-03-04

Documents

1 file
  • 4
    ownership.xmlPrimary

    4